Late-onset familial Mediterranean fever in Japan

Abstract

Objectives: Most patients with familial Mediterranean fever (FMF) have their first attack at age < 20 years. Information about late-onset (age ≥40 years) FMF is limited. We aimed to evaluate the demographic, clinical, and genetic characteristics of late-onset FMF patients in the Japanese population.

Methods: We retrospectively analyzed 292 patients with FMF. Patients were divided into three groups according to age of disease onset: Group I, ≤19 years; Group II, 20–39 years; and Group III, ≥40 years.

Results: Of 292 patients, 44 (15.1%) experienced their first attack at age ≥40 years. While high fever (97.7%) and arthritis (45.5%) were common symptoms in Group III patients, peritonitis (40.9%) and pleuritis (25.0%) were significantly lower than in other groups. The frequency of patients carrying p.M694I (18.2%), which is the most representative mutation in Japan, was significantly lower in Group III than in Group I. The response to colchicine therapy was good (95.1%) and similar in all groups.

Conclusions: In Japan, more patients than expected had late-onset FMF. They had a milder form of disease, with less frequent peritonitis and pleuritis. The response to colchicine treatment was good. Clinicians should consider FMF for patients with unexplained recurrent febrile episodes, regardless of age.

Keywords:

• Colchicine
• familial Mediterranean fever
• fever
• late onset
• MEFV mutation

Acknowledgments

The authors thank all the doctors for participating in the current study. The authors thank Ms. Sonomi Nagasaki and Ms. Emi Nomura for their technical support. This work was supported by JSPS KAKENHI (Grant Numbers JP26860447 and JP17K15892).

Conflict of interest

None.